Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis
Public ClinicalTrials.gov record NCT05979779. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 6-Month, Randomized, Double-Blind, Placebo-controlled, Phase 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a phase 2 randomized, double-blind, placebo-controlled parallel group study of 3 dose levels of HU6 in subjects with nonalcoholic steatohepatitis (NASH). Six months (26 weeks) of dosing is planned, and subjects will be followed for safety, efficacy, pharmacodynamics (PD), and pharmacokinetics (PK) during this time. The end-of-study visit will take place approximately 4 weeks after the last dose of the study drug (Week 30).
Study identification
- NCT ID
- NCT05979779
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 219 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 5, 2023 (Actual)
- Primary completion
- Jan 21, 2025 (Actual)
- Completion
- Jun 2025 (Estimated)
- Last update posted
- Apr 18, 2025
2023 – 2025
United States locations
- U.S. sites
- 20
- U.S. states
- 6
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| ProSciento CRU | Chula Vista | California | 91911 | — |
| Velocity Clinical Research | Los Angeles | California | 90057 | — |
| Catalina Research Institute | Montclair | California | 91763 | — |
| Northern California Research Center | Sacramento | California | 95821 | — |
| Metro Clinical Trials | San Bernardino | California | 92404 | — |
| Synergy Healthcare | Bradenton | Florida | 34208 | — |
| ABMED Clinical Research Corp. | Cape Coral | Florida | 33914 | — |
| Southwest General Healthcare Center | Fort Myers | Florida | 33907 | — |
| Miami Clinical Research | Miami | Florida | 33155 | — |
| Advanced Clinical Research | Miami | Florida | 33156 | — |
| Century Research, LLC | Miami | Florida | 33173 | — |
| Entrust Clinical Research | Miami | Florida | 33176 | — |
| Panax Clinical Research | Miami Lakes | Florida | 33014 | — |
| Tandem Clinical Research | Marrero | Louisiana | 70072 | — |
| CenExel HRI | Berlin | New Jersey | 08009 | — |
| Lillestol Research | Fargo | North Dakota | 58104 | — |
| IMA Clinical Research-Austin | Austin | Texas | 78745 | — |
| Mt Olympus Medical Research | Houston | Texas | 77030 | — |
| Houston Research Institute | Houston | Texas | 77079 | — |
| Texas Liver Institute | San Antonio | Texas | 78215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05979779, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 18, 2025 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05979779 live on ClinicalTrials.gov.